Comparing Lumigan vs Vyzulta
| Lumigan (bimatoprost) | Vyzulta (latanoprostene bunod) |
|
|---|
| Lumigan (bimatoprost) | Vyzulta (latanoprostene bunod) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Lumigan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma - Open Angle, Glaucoma/Intraocular Hypertension. Vyzulta may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma, Open Angle
Popular comparisons
|
|||||||
| More about Lumigan (bimatoprost) | More about Vyzulta (latanoprostene bunod) | ||||||||
| Ratings & Reviews | |||||||||
|
Lumigan has an average rating of 5.2 out of 10 from a total of 25 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 36% reported a negative effect. |
Vyzulta has an average rating of 6.4 out of 10 from a total of 12 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Lumigan side effects |
View all Vyzulta side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Vyzulta prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other bimatoprost brands include: Durysta |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
0.75 hours |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 7 drugs are known to interact with Lumigan:
|
A total of 7 drugs are known to interact with Vyzulta:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | |||||||||
|
March 16, 2001 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.